Diabetes and pancreatic cancer has been found to be linked in a study conducted by Mayo Clinic. The study found that 40% of patients with pancreatic cancer were previously diagnosed with diabetes many months before or for up to two years in some cases.
Lead author of the study Suresh Chari, M.D., who is also the gastroenterologist at the Mayo Clinic, said that they are now certain that for the patients who have pancreatic cancer the diabetes is caused by cancer and not vice versa.
Their next goal now is to find a biomarker for the diabetes brought about by pancreatic cancer so that they can check the newly diagnosed diabetic if they have early pancreatic cancer. This way they can present surgical treatment as early as possible.
Pancreatic cancer is the fourth leading cause of death in the United States and since they usually do not show symptoms for this early on, by the time it is diagnosed, the stage is so advanced, surgery is not possible. That is why less than 5% live five years after the diagnosis is made.
The researchers reviewed the records of 736 patients with pancreatic cancer and 1875 healthy people with the record of fasting blood sugar data. They found that 40% of the patients with pancreatic cancer were diagnosed with diabetes while in the healthy people group, only 20% had diabetes.
Diabetes that is induced by pancreatic cancer is less common than type 2 diabetes. Their previous study showed that only one of every 125 who were 50 years old and over and who were newly diagnosed with diabetes will be diagnosed with pancreatic cancer.
Dr. Wang and company said that around 80% of patients who have pancreatic cancer are intolerant to glucose or what they call frank diabetes in another research. From this finding, they came up with two hypotheses. One is that the pancreatic cancer leads to associated diabetes and second is that diabetes promotes the development of pancreatic cancer. There has been proof supporting these two hypotheses.
They will continue their work on this so that they can catch pancreatic cancer early enough to make it possible to do a surgical intervention more successfully. As for me, I am only too glad to know that this study shows that this condition is not a diabetes complication. Enough already! I don't want to write anymore about the link between diabetes and pancreatic cancer.
Search This Blog
Wednesday, March 17, 2010
Wednesday, March 10, 2010
Encouraging Data for Type 2 Diabetes
Obesity and type 2 diabetes gets a promising data as announced by Genaera Corporation. They said that their drug candidate to treat obesity and type 2 diabetes, trodusquemine or MSI-1436, shows noticeable improvement in obese mice.
The same drug has also lowered the plasma insulin levels and improved the glucose tolerance and fasting blood glucose in animals that were hyperglycemic. This announcement was made at the Diabetes Mellitus Symposia in Breckenridge, Colorado.
In addition to the marked improvement in the aforementioned areas, the effects were maintained. Here's how they found this out. They administered the MSI-1436 to the diet-induced obese mice four weekly treatments. The result was significant in the sense that there was marked improvement in the level of plasma insulin.
In addition, the glucose tolerance improvement was maintained when the mice were administered the same drug weekly for 122 days. How did they find this out? By testing the oral glucose tolerance, and so they concluded that long periods of treatment will maintain the marked improvement for obesity and type 2 diabetes.
It looks like that the MSI-1436 has properties that are anti-diabetic. What are these properties? Maintained improvement in glucose tolerance and fasting blood glucose, improved sensitivity to insulin and lowering of plasma insulin levels are the anti-diabetic properties the scientists found from their experiments.
Genaera president and CEO Jack Armstrong said that with the promising data they obtained, they will keep on exploring MSI-1436 as a treatment for obesity and type 2 diabetes. They are going ahead with assessing the potential of this drug that will impact both obesity and type 2 diabetes.
The same drug has also lowered the plasma insulin levels and improved the glucose tolerance and fasting blood glucose in animals that were hyperglycemic. This announcement was made at the Diabetes Mellitus Symposia in Breckenridge, Colorado.
In addition to the marked improvement in the aforementioned areas, the effects were maintained. Here's how they found this out. They administered the MSI-1436 to the diet-induced obese mice four weekly treatments. The result was significant in the sense that there was marked improvement in the level of plasma insulin.
In addition, the glucose tolerance improvement was maintained when the mice were administered the same drug weekly for 122 days. How did they find this out? By testing the oral glucose tolerance, and so they concluded that long periods of treatment will maintain the marked improvement for obesity and type 2 diabetes.
It looks like that the MSI-1436 has properties that are anti-diabetic. What are these properties? Maintained improvement in glucose tolerance and fasting blood glucose, improved sensitivity to insulin and lowering of plasma insulin levels are the anti-diabetic properties the scientists found from their experiments.
Genaera president and CEO Jack Armstrong said that with the promising data they obtained, they will keep on exploring MSI-1436 as a treatment for obesity and type 2 diabetes. They are going ahead with assessing the potential of this drug that will impact both obesity and type 2 diabetes.
Thursday, March 4, 2010
Beta Cells Progenitors Discovery Shows Promise
Beta cells progenitors researchers at the Vrije Universiteit Brussel's Diabetes Research Center were able to separate the pancreatic cells from adult mice. These can produce insulin. They have been indefinable before so their existence has been questionable.
Cell, the scientific journal, published the findings in the January 25 issue. Harry Heimberg's research team did the report. This shows promise in the sense that if the progenitor cells are also found in human pancreas, then it may leave the door open for new treatments for diabetic patients.
We know that the diabetics do not have enough insulin because their beta cells that produce it are not sufficient. And to move the main source of energy from the blood to the cells, insulin is needed. The primary source of energy is sugar.
It took so long to discover these progenitors cells because for one thing they are in short supply. Then it was difficult to get these cells to act. What the Heimberg's research team did to solve these challenges was to fasten the channel that uses up the digestive enzymes from the pancreas.
Clamping the channel resulted in the activation of the progenitor cells. The investigators then did some genetic labeling on these cells to make it possible to detect and separate them. Here is the good part. During the process, the beta cells doubled in quantity. What does this mean to us?
If more studies on this are pursued to find out if these progenitor cells are also in humans and the factors that make them produce insulin, then there will be more chance for people to undergo the successful treatment of beta cells transplantation.
This has been a controversial issue in diabetes research but in this recent study, beta cells have been generated and they are responsive to glucose. They are found in the pancreas of the adult mice and can be activated to increase the beta cell mass.
This research has provided the proof needed to show that cells in the adult pancreas exist and have the potential to generate beta cells. Needless to say, discovering the molecules involved in such generation will be a rewarding though challenging endeavor.
As long as there is inadequate supply of beta cells, this successful therapy of transplantation is limited because of insufficient donor organs. Getting large supplies of these will solve this problem and will make the transplantation available to more people if there are enough beta cells progenitors.
Cell, the scientific journal, published the findings in the January 25 issue. Harry Heimberg's research team did the report. This shows promise in the sense that if the progenitor cells are also found in human pancreas, then it may leave the door open for new treatments for diabetic patients.
We know that the diabetics do not have enough insulin because their beta cells that produce it are not sufficient. And to move the main source of energy from the blood to the cells, insulin is needed. The primary source of energy is sugar.
It took so long to discover these progenitors cells because for one thing they are in short supply. Then it was difficult to get these cells to act. What the Heimberg's research team did to solve these challenges was to fasten the channel that uses up the digestive enzymes from the pancreas.
Clamping the channel resulted in the activation of the progenitor cells. The investigators then did some genetic labeling on these cells to make it possible to detect and separate them. Here is the good part. During the process, the beta cells doubled in quantity. What does this mean to us?
If more studies on this are pursued to find out if these progenitor cells are also in humans and the factors that make them produce insulin, then there will be more chance for people to undergo the successful treatment of beta cells transplantation.
This has been a controversial issue in diabetes research but in this recent study, beta cells have been generated and they are responsive to glucose. They are found in the pancreas of the adult mice and can be activated to increase the beta cell mass.
This research has provided the proof needed to show that cells in the adult pancreas exist and have the potential to generate beta cells. Needless to say, discovering the molecules involved in such generation will be a rewarding though challenging endeavor.
As long as there is inadequate supply of beta cells, this successful therapy of transplantation is limited because of insufficient donor organs. Getting large supplies of these will solve this problem and will make the transplantation available to more people if there are enough beta cells progenitors.
Thursday, February 25, 2010
Leptin and Diabetes Connection
Leptin and diabetes as a topic has been touched upon by the Chinese Academy of Sciences researchers at the Northwest Institute of Plateau Biology. They reported that the development that may happen to the pika's leptin protein may be due to the cold and not hypoxia. The pika is a mammal that is normally cold-adaptive.
Pikas are small and do not hibernate. They only live in cold zones at high elevation or at high altitude. They are restricted to the region of Qinghai-Tibet Plateau. This area is sometimes called the roof of the world as it has an average altitude of >3000 meters and located at high latitude.
Climate-wise, the two notable characteristics of the Plateau are hypoxia and low temperature so during their development, the pikas have become tolerant to low temperature and hypoxic. Their metabolic rates are high and so is their oxygen use ratio in order to deal with the cold and hypoxic region.
Dr. Zhao said that their research team showed that when compared with other similar mammals, the pika leptin has a unique characteristic indicating its functional variation. This may be a common trait of the whole pika family due to the cold survival location.
Since the leptin plays a vital role in the metabolism of energy, glucose and lipid, this study clarifies the significant ecology issues of the way small mammals respond to very stressful environment. It also explains the importance of the pika leptin's role in the way the pikas adjust to where they live.
This might help us understand and recognize other ways to treat the diseases that are linked to metabolic disorders such as diabetes and obesity. Dr. Zhao said that their research team is now continuing their investigations of the pika leptin in order to confirm their finding.
I have long been interested in this topic since I first read it a few years ago. After going back to research it further, I found there has been a giant leap in its progress. Now studies have proven that it is not only beneficial for weight loss but rather a small amount of it can help reverse the diabetes.
The researcher from Rockefeller University, Jeffrey Friedman mentioned in the news release that they found the significant impact of this potent leptin was undetectable. So now we have another weapon in our arsenal to help in our battle and that is the story of leptin and diabetes.
Pikas are small and do not hibernate. They only live in cold zones at high elevation or at high altitude. They are restricted to the region of Qinghai-Tibet Plateau. This area is sometimes called the roof of the world as it has an average altitude of >3000 meters and located at high latitude.
Climate-wise, the two notable characteristics of the Plateau are hypoxia and low temperature so during their development, the pikas have become tolerant to low temperature and hypoxic. Their metabolic rates are high and so is their oxygen use ratio in order to deal with the cold and hypoxic region.
Dr. Zhao said that their research team showed that when compared with other similar mammals, the pika leptin has a unique characteristic indicating its functional variation. This may be a common trait of the whole pika family due to the cold survival location.
Since the leptin plays a vital role in the metabolism of energy, glucose and lipid, this study clarifies the significant ecology issues of the way small mammals respond to very stressful environment. It also explains the importance of the pika leptin's role in the way the pikas adjust to where they live.
This might help us understand and recognize other ways to treat the diseases that are linked to metabolic disorders such as diabetes and obesity. Dr. Zhao said that their research team is now continuing their investigations of the pika leptin in order to confirm their finding.
I have long been interested in this topic since I first read it a few years ago. After going back to research it further, I found there has been a giant leap in its progress. Now studies have proven that it is not only beneficial for weight loss but rather a small amount of it can help reverse the diabetes.
The researcher from Rockefeller University, Jeffrey Friedman mentioned in the news release that they found the significant impact of this potent leptin was undetectable. So now we have another weapon in our arsenal to help in our battle and that is the story of leptin and diabetes.
Wednesday, February 17, 2010
Diabetes and Pollution Linked?
Diabetes and pollution was the topic of discussion in Lancet. In its issue it reported on the need for research on the possible link between the pollution in the environment and diabetes. Drs. Julian Griffin and Oliver Jones from Cambridge emphasized the need to investigate this probable link.
Not much is known about the link between type 2 diabetes and pollution in the environment so the two doctors encouraged the investigation of the POP's (persistent organic pollutants) effect on resistance to insulin which we know can lead to diabetes.
In their presentation, both Drs. Griffin and Jones mentioned the research on the POP's link that was reviewed by their peers. This included the study conducted by Dr. D. Lee which showed an extra strong connection between the type 2 diabetes risk and the POP's level in the blood.
The POP that was particularly found is the one known as organochlorine compounds. It is interesting to note that in the research conducted by Dr. Lee there was no correlation between diabetes and obesity among those who had low POP's in their blood.
So it looked like that thin people whose POP's level in their blood were high had a higher risk for diabetes than if they were overweight but with low readings of POP. This indicates the correlation between diabetes and the environmental pollution. Of course there are other diabetes risk factors.
Then, Dominion, a Canadian newspaper, reported that the evidence between diabetes and pollution is growing especially among the native people. One of every four adults in this group who live in Canadian reserves have type 2 diabetes. According to the National Pollutant Release Inventory of Environment Canada, 212 of these communities live near pulp mills and others that produce furans and dioxins.
Dr. Jones said that this possible link does not routinely mean that environmental pollution causes diabetes but if there is a correlation, the implications could be huge. There is not much data on this as of this writing because the focus of researches is on obesity and heredity. Environmental pollution has not been considered as a possible cause of the disease.
This hypotheses on the POP effect should be tested by using tissue or cell cultures to be certain that diabetes can occur, Dr. Jones suggested. If it is found to be the cause then a therapeutic method can be developed to help people who are affected by this. So there is a need for more studies on diabetes and pollution.
Not much is known about the link between type 2 diabetes and pollution in the environment so the two doctors encouraged the investigation of the POP's (persistent organic pollutants) effect on resistance to insulin which we know can lead to diabetes.
In their presentation, both Drs. Griffin and Jones mentioned the research on the POP's link that was reviewed by their peers. This included the study conducted by Dr. D. Lee which showed an extra strong connection between the type 2 diabetes risk and the POP's level in the blood.
The POP that was particularly found is the one known as organochlorine compounds. It is interesting to note that in the research conducted by Dr. Lee there was no correlation between diabetes and obesity among those who had low POP's in their blood.
So it looked like that thin people whose POP's level in their blood were high had a higher risk for diabetes than if they were overweight but with low readings of POP. This indicates the correlation between diabetes and the environmental pollution. Of course there are other diabetes risk factors.
Then, Dominion, a Canadian newspaper, reported that the evidence between diabetes and pollution is growing especially among the native people. One of every four adults in this group who live in Canadian reserves have type 2 diabetes. According to the National Pollutant Release Inventory of Environment Canada, 212 of these communities live near pulp mills and others that produce furans and dioxins.
Dr. Jones said that this possible link does not routinely mean that environmental pollution causes diabetes but if there is a correlation, the implications could be huge. There is not much data on this as of this writing because the focus of researches is on obesity and heredity. Environmental pollution has not been considered as a possible cause of the disease.
This hypotheses on the POP effect should be tested by using tissue or cell cultures to be certain that diabetes can occur, Dr. Jones suggested. If it is found to be the cause then a therapeutic method can be developed to help people who are affected by this. So there is a need for more studies on diabetes and pollution.
Wednesday, February 10, 2010
Obesity and Diabetes, Could They Make Type 2 Diabetes Health Loss Double by 2023?
Obesity and diabetes must be in the minds of the University of Queensland researchers when they said health loss due to type 2 diabetes will be more than twice by 2023 in Australia. This is the prediction of the University of Queensland scientists who also said that health loss through the other major reasons will be down.
To arrive at the above conclusion, the researchers used a measurement called DALY which is acronym for "disability adjusted life year". They say that one DALY is equals to one year of healthy life that is lost. The DALY stands for the difference between the present health status and the model for reaching old age.
How did they arrive at their prediction? They evaluated and calculated the data from 1993 to 2003 in Australia regarding the injury and disease. This study by Stephen Begg et al then measured the loss of health from these and other factors.
Stephen Begg said that the health loss among those in the lower economic status is higher by 31.7%. When comparing the population between those living in remote areas and big cities, the health loss in the former is 26.5% higher.
These researchers examined 14 risk factors like smoking, alcohol intake, increased body mass, lack of physical activity and high blood pressure. Dr. Vos said that all these can be eliminated through intervention. So it follows that health loss through diabetes can be stopped as well.
Dr. Vos added that there is a need for new ways so that the Australians will be motivated to lose weight just like the campaign they had about smoking that lowered the risk for cardiovascular disease. This way health loss through diabetes could be reduced too.
Two things I like about this report of mine. One is that it mentions the fact that all the risk factors can be eliminated through proper intervention. In such a case, can diabetes be far behind? Of course not. It can be stopped as well. If not through lifestyle changes, then by golly, we are going to do it through intervention, however painful that could be.
The other thing that I like about this report is that it mentions about getting motivated to lose weight. Really, obesity is quite a problem that needs to be addressed and met head on. I am glad to hear that the first lady, Michelle Obama is stepping on the plate and getting an initiative to fight both obesity and diabetes.
To arrive at the above conclusion, the researchers used a measurement called DALY which is acronym for "disability adjusted life year". They say that one DALY is equals to one year of healthy life that is lost. The DALY stands for the difference between the present health status and the model for reaching old age.
How did they arrive at their prediction? They evaluated and calculated the data from 1993 to 2003 in Australia regarding the injury and disease. This study by Stephen Begg et al then measured the loss of health from these and other factors.
Stephen Begg said that the health loss among those in the lower economic status is higher by 31.7%. When comparing the population between those living in remote areas and big cities, the health loss in the former is 26.5% higher.
These researchers examined 14 risk factors like smoking, alcohol intake, increased body mass, lack of physical activity and high blood pressure. Dr. Vos said that all these can be eliminated through intervention. So it follows that health loss through diabetes can be stopped as well.
Dr. Vos added that there is a need for new ways so that the Australians will be motivated to lose weight just like the campaign they had about smoking that lowered the risk for cardiovascular disease. This way health loss through diabetes could be reduced too.
Two things I like about this report of mine. One is that it mentions the fact that all the risk factors can be eliminated through proper intervention. In such a case, can diabetes be far behind? Of course not. It can be stopped as well. If not through lifestyle changes, then by golly, we are going to do it through intervention, however painful that could be.
The other thing that I like about this report is that it mentions about getting motivated to lose weight. Really, obesity is quite a problem that needs to be addressed and met head on. I am glad to hear that the first lady, Michelle Obama is stepping on the plate and getting an initiative to fight both obesity and diabetes.
Wednesday, February 3, 2010
Diabetics Have New Hope in New Medical Center
Dr. Mariam Harmas said the new BDI million diabetes education center announced will have a gym, swimming pool and the Bahrain Diabetes Society offices. The announcement came as a 26-year old woman advised people to follow their doctor's order so that they won't lose their kidney and feet like what happened to her for ignoring her diabetes.
The center for rehabilitation and diabetes education will be located in A'ali. They are requesting sponsors for the project and giving statistics on the number of type 1 diabetics that has grown to more than twice from 1993 figures in Bahrain.
The consultant pediatrician at the Salmaniya Medical complex, Dr. Mansoor Rajab, said the number is still growing. Dr. Rajab is also a diabetologist and endocrinologist. He said that the figure in 1993 showed that seven to eight people per 100,000 had type 1 diabetes. Now that number has grown to 20 people suffering from type 1 diabetes out of every 100,000.
In Bahrain, there are now 1000 children suffering from type 1 diabetes, Dr. Rajab added. And the statistics for type 2 diabetes is not any better. Due to inactive lifestyle and unhealthy meals, the number of type 2 sufferers is also growing. Diabetes now affects 35% of women and 25% of men.
The discussion on the alarming statistics was held when the 2007 ambassador of ACHC (Arab Children Health Congress) Habiba Al Tawqi visited Bahrain and spoke to diabetic children. She said it is very important to control diabetes by taking the medication and changing lifestyle.
Ms. Tawqi said she lost both her feet and kidney because she didn't take her medication regularly and didn't eat a healthy diet. She is a graduate of Omani tourism and has been diabetic starting at two years old. But she only started her problem in 1998 when she rebelled against her parents and doctors and didn't follow their advice.
But now she learned how to fight because she does not want to lose anything more. Her goal is to talk to as many teenagers as possible so they will understand the condition better. The wife of the ruler of Dubai Shaikh Mohammed bin Rashid Al Maktoum, Princess Haya bint Al Hussain, sponsored Ms. Tawqi's visit.
The head of the Health and Medical Services in Dubai, Wafaa Ayesh, said people with diabetes could live a long life with a healthy lifestyle and medication. By this lifestyle, he meant, eating a healthy diet and having enough physical activity.
The center for rehabilitation and diabetes education will be located in A'ali. They are requesting sponsors for the project and giving statistics on the number of type 1 diabetics that has grown to more than twice from 1993 figures in Bahrain.
The consultant pediatrician at the Salmaniya Medical complex, Dr. Mansoor Rajab, said the number is still growing. Dr. Rajab is also a diabetologist and endocrinologist. He said that the figure in 1993 showed that seven to eight people per 100,000 had type 1 diabetes. Now that number has grown to 20 people suffering from type 1 diabetes out of every 100,000.
In Bahrain, there are now 1000 children suffering from type 1 diabetes, Dr. Rajab added. And the statistics for type 2 diabetes is not any better. Due to inactive lifestyle and unhealthy meals, the number of type 2 sufferers is also growing. Diabetes now affects 35% of women and 25% of men.
The discussion on the alarming statistics was held when the 2007 ambassador of ACHC (Arab Children Health Congress) Habiba Al Tawqi visited Bahrain and spoke to diabetic children. She said it is very important to control diabetes by taking the medication and changing lifestyle.
Ms. Tawqi said she lost both her feet and kidney because she didn't take her medication regularly and didn't eat a healthy diet. She is a graduate of Omani tourism and has been diabetic starting at two years old. But she only started her problem in 1998 when she rebelled against her parents and doctors and didn't follow their advice.
But now she learned how to fight because she does not want to lose anything more. Her goal is to talk to as many teenagers as possible so they will understand the condition better. The wife of the ruler of Dubai Shaikh Mohammed bin Rashid Al Maktoum, Princess Haya bint Al Hussain, sponsored Ms. Tawqi's visit.
The head of the Health and Medical Services in Dubai, Wafaa Ayesh, said people with diabetes could live a long life with a healthy lifestyle and medication. By this lifestyle, he meant, eating a healthy diet and having enough physical activity.
Subscribe to:
Posts (Atom)